←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Immunotherapy
Kim Margolin
MD
🏢Saint John's Cancer Institute🌐USA
Senior Scientific Advisor in Melanoma
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kim Margolin is a veteran melanoma immunotherapy investigator who led early high-dose IL-2 studies and pivotal trials of nivolumab and ipilimumab in melanoma brain metastases. She has shaped melanoma immunotherapy practice across generations.
Share:
🧪Research Fields 研究领域
high-dose IL-2
nivolumab ipilimumab melanoma
brain metastases immunotherapy
cytokine therapy
melanoma history
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kim Margolin 的研究动态
Follow Kim Margolin's research updates
留下邮箱，当我们发布与 Kim Margolin（Saint John's Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment